Belle Health AI Technologies

About Belle Health AI Technologies

Belle Health AI Technologies Ltd, known as Belle, is a women’s health company focused on developing digital medical devices and solutions to empower women in managing menstrual cycle-related challenges, with an emphasis on female hormonal health conditions, especially premenstrual disorders such as PMDD (Premenstrual Dysphoric Disorder) and PMS (Premenstrual Syndrome).

Founded by Rafael and Victoria at the University of Cambridge, the company combines medical and engineering expertise to revolutionize female health through precision medicine technology. Belle offers an app that serves as a health ally to understand, monitor, and manage PMDD symptoms through customizable tracking, personalized guidance, and evidence-based cognitive-behavioral therapy techniques.

Mission and Goals

Belle aims to bridge the gender data gap and improve overall health and well-being of women facing unique hormonal health challenges. The company is dedicated to enhancing diagnosis, care, and management of premenstrual disorders through a holistic, evidence-based, and tech-driven approach. Belle seeks to empower women to take control of their health journeys and use their experiences as strengths, providing long-term health, well-being, and resilience.

Supported by leading scientists and with partnerships in clinical research, Belle’s solutions are scientifically supported and focused on rewriting the narrative around women's hormonal health with practical tools, symptom relief, and medically endorsed reporting.